BioCentury
ARTICLE | Finance

Financial Engineering Payoff

Cardio play Ikaria files for $200M IPO; neurology play NuPathe gets in the queue

May 17, 2010 7:00 AM UTC

Profitable cardiovascular and pulmonary company Ikaria Inc. filed for an IPO on Friday last week to raise up to $200 million.

Ikaria markets INOmax nitric oxide for inhalation to treat term and near-term infants with hypoxic respiratory failure. The company had $274.6 million in revenue in 2009...